What is PMGC Holdings Inc. (ELAB) stock price today?

PMGC Holdings Inc. (ELAB) is currently trading at $3.08, down 1.6% today.

What is ELAB P/E ratio?

PMGC Holdings Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ELAB return on equity (ROE)?

PMGC Holdings Inc.'s return on equity (ROE) is -118.11%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is PMGC Holdings Inc.'s market cap?

PMGC Holdings Inc. has a market capitalization of $1.40M.

NCM · Biotechnology

PMGC Holdings Inc. (ELAB) Stock

$3.08 -1.60% NCM: ELAB Healthcare

Valuation

Metric	Value
Price	$3.08
Market Cap	$1.40M
P/E Ratio	0.00
P/B Ratio	0.10
P/S Ratio	0.59
EPS (TTM)	$-378.74
52-Week High	$2671.20
52-Week Low	$2.58
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-118.11%
ROA	-36.88%
ROCE	-57.92%
Gross Margin	-700.00%
Operating Margin	-700.00%
Net Margin	-522.97%
Debt/Equity	0.83
Current Ratio	1.75

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$1.0M	$0	$2.0M	$1.0M
Operating Profit	$-1.0M	$-2.0M	$-1.0M	$-2.0M	$-7.0M
Net Profit	$-1.0M	$-2.0M	$-4.0M	$-6.0M	$-8.0M
EPS	$-887.71	$-158.40	$-1511.43	$-65923.20	$-3787.40
Op Margin	-94928.9%	-233.4%	—	-75.7%	-1250.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$1.0M	$2.0M	$5.0M	$9.0M	$13.0M
Total Liabilities	$0	$1.0M	$1.0M	$2.0M	$5.0M
Cash	$0	$1.0M	$3.0M	$4.0M	$5.0M
Borrowings	$0	$0	$0	$0	$3.0M

Latest News

NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload Technology Across Defense, Aerospace and Maritime Applications GlobeNewswire · Jul 13, 2026 PMGC Holdings Advances EL-22 FACS Analysis to Support Manufacturing Comparability InvestorsHub · Jul 10, 2026 NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression GlobeNewswire · Jul 10, 2026 PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace GlobeNewswire · Jul 6, 2026 NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences GlobeNewswire · Jul 1, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-1.0M	$-2.0M	$-5.0M	$-5.0M	$-6.0M
Investing Cash Flow	$0	$0	$0	$-1.0M	$-3.0M
Financing Cash Flow	$0	$0	$-1.0M	$0	$4.0M
Net Cash Flow	$0	$1.0M	$2.0M	$1.0M	$1.0M
Free Cash Flow	$-1.0M	$-2.0M	$-5.0M	$-5.0M	$-6.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.23
FCF Yield	-588.54%
Quick Ratio	1.30
Interest Coverage	-5.56
Return 1Y	-99.44%
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held9.99%

Institutions Held1.92%

Institutions Float Held2.13%

Institutional Holder	Shares	Report Date
Jane Street Group, LLC	31,594	2026-03-31
Schonfeld Strategic Advisors Llc	14,800	2026-03-31
Morgan Stanley	15,000	2026-03-31
UBS Group AG	1,302	2026-03-31
IFP Advisors, Inc	1,000	2026-06-30

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ATXIAvenue Therapeutics, Inc.	$0.26	-32.94%	-0.49	$856691	0.00%
BCTXZBriaCell Therapeutics Corp. Warrant	$0.10	+8.47%	-0.30	$188186	0.00%
DRMADermata Therapeutics, Inc.	$1.05	-2.34%	-0.25	$4.20M	0.00%
MLECMoolec Science SA	$2.08	-50.36%	-0.02	$1.51M	0.00%
NCELNewcelX Ltd.	$3.05	-2.09%	8.67	$1.37M	0.00%

About PMGC Holdings Inc.

PMGC Holdings Inc. is led by CEO Graydon Bensler, employs 2 people, headquartered in US, publicly traded since 2023.

PMGC Holdings Inc. (ELAB) stock trades at $3.08 with a market capitalization of $1.40M. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.10, price-to-sales of 0.59. Over the past 52 weeks the stock has ranged between $2.58 and $2671.20, and currently trades 99.9% below its 52-week high.

On profitability, PMGC Holdings Inc. generates a return on equity (ROE) of -118.11%, return on capital employed of -57.92%, an operating margin of -700.00%, a net profit margin of -522.97%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides